ViiV Healthcare Overview
- Year Founded
-
2009
- Status
-
Private
- Employees
-
700
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
2
- Investments
-
1
ViiV Healthcare General Information
Description
Operator of a global specialist HIV company intended to deliver innovative new options for the care and treatment of people living with HIV/AIDS. The company's products include dolutegravir, zidovudine, fosamprenavi, maraviroc, abacavir, and nelfinavir and delavirdine mesylate and provides nucleoside reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitor, protease inhibitors, and CCR5 antagonist for the treatment of AIDS.
Contact Information
Website
www.viivhealthcare.comCorporate Office
- 980 Great West Road
- Brentford TW8 9GS
- England, United Kingdom
Corporate Office
- 980 Great West Road
- Brentford TW8 9GS
- England, United Kingdom
ViiV Healthcare Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
ViiV Healthcare Comparisons
Industry
Financing
Details
ViiV Healthcare Competitors (1)
One of ViiV Healthcare’s competitors is Gilead Sciences, a Formerly VC-backed company based in Foster City, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Gilead Sciences | Formerly VC-backed | Foster City, CA |
ViiV Healthcare Patents
ViiV Healthcare Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2023275545-A1 | Piperazine derivatives useful in hiv therapy | Pending | 27-May-2022 | ||
| EP-4532488-A1 | Piperazine derivatives useful in hiv therapy | Pending | 27-May-2022 | ||
| JP-2025518076-A | Piperazine derivatives useful in hiv treatment | Pending | 27-May-2022 | ||
| CA-3241017-A1 | Combination therapies for hiv infections and uses thereof | Pending | 17-Dec-2021 | ||
| AU-2022409827-A1 | Combination therapies for hiv infections and uses thereof | Pending | 17-Dec-2021 | C07K16/1063 |
ViiV Healthcare Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
ViiV Healthcare Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
ViiV Healthcare Investments (1)
ViiV Healthcare’s most recent deal was a Corporate Asset Purchase with Bristol-Myers Squibb (HIV R&D assets) for . The deal was made on 22-Feb-2016.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Bristol-Myers Squibb (HIV R&D assets) | 22-Feb-2016 | Corporate Asset Purchase | Buildings and Property |
ViiV Healthcare FAQs
-
When was ViiV Healthcare founded?
ViiV Healthcare was founded in 2009.
-
Where is ViiV Healthcare headquartered?
ViiV Healthcare is headquartered in Brentford, United Kingdom.
-
What is the size of ViiV Healthcare?
ViiV Healthcare has 700 total employees.
-
What industry is ViiV Healthcare in?
ViiV Healthcare’s primary industry is Other Healthcare Services.
-
Is ViiV Healthcare a private or public company?
ViiV Healthcare is a Private company.
-
What is ViiV Healthcare’s current revenue?
The current revenue for ViiV Healthcare is .
-
Who are ViiV Healthcare’s investors?
Shionogi & Co., GSK, and Pfizer (Pharmaceuticals) have invested in ViiV Healthcare.
-
Who are ViiV Healthcare’s competitors?
Gilead Sciences is a competitor of ViiV Healthcare.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
